The coagulation cascade consists of a series of surface reactions where coa
gulation factors and cofactors assemble on a negatively charged phospholipi
d surface. In this process, locally formed proteases activate surface-bound
substrates and culminate in the formation of thrombin that transforms fibr
inogen into a polymerized fibrin network. Activation of protein C, a potent
anticoagulant, requires also phospholipid surfaces. It is possible that an
tibodies may originate from an immunological response to neoepitopes genera
ted by the formation of these short-lived protein-phospholipid complexes. T
hese antibodies then may recognize some of the phospholipid-bound proteins
and interfere thereby with their procoagulant or anticoagulant activities.
beta (2)-glycoprotein I, prothrombin and components of the protein C pathwa
y are some of the most frequent protein cofactors of these antibodies. Anti
genic heterogeneity and single antibody targeting cannot explain the pathop
hysiology of associated thrombotic accidents.